Search

everythinglearnresearchcommunity

for

Search:↓

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

UT-018 speeds up wound healing and boosts hair growth in mice.

Some breast cancer chemotherapy can cause permanent hair loss.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

Tofacitinib helped a woman regrow hair with no major side effects.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Targeting PTEN can improve healing in venous leg ulcers.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.